{"nct_id":"NCT00358293","title":"Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity","status":"COMPLETED","status_verified_date":"2007-04","start_date":"2006-12","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2007-02","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TEVA"]}